Plasma protein binding and erythrocyte partitioning of nicardipine in vitro.
Using isotope techniques, equilibrium dialysis, and incubation experiments, we characterized the binding of nicardipine to isolated plasma proteins, human serum, blood cells, and platelets. Nicardipine was mainly bound to lipoproteins, orosomucoïd, albumin, and erythrocytes in human blood. Nicardipine, pindolol, and imipramine were found to share the same site on orosomucoïd. The determinants of nicardipine binding to lipoproteins were triglycerides, phospholipids, and cholesterol ester. Nicardipine partitioned into erythrocytes, showing a constant ratio of distribution between the intra- and extracellular compartments. Nicardipine partitioned less to erythrocytes when increasing amounts of binding plasma proteins were present in the extracellular compartment. In human blood, 12 to 18% of total nicardipine was present in erythrocytes. The overall binding of nicardipine in serum varied from 98 to 99.5% and correlated with serum orosomucoïd and serum lipid concentrations.
S
S
Urien
E
E
Albengres
A
A
Comte
J R
JR
Kiechel
J P
JP
Tillement
D001798:Blood Proteins / Q000378:metabolism*; D002784:Cholesterol / Q000378:metabolism; D004655:Emulsions; D004912:Erythrocytes / Q000378:metabolism*; D006801:Humans; D006863:Hydrogen-Ion Concentration; D066298:In Vitro Techniques; D009529:Nicardipine; D009543:Nifedipine / Q000031:analogs & derivatives* / Q000097:blood; D009961:Orosomucoid / Q000378:metabolism; D010713:Phosphatidylcholines / Q000378:metabolism; D011485:Protein Binding; D014304:Triolein / Q000378:metabolism; D014665:Vasodilator Agents / Q000097:blood*
D001798:Blood Proteins; D004655:Emulsions; D009961:Orosomucoid; D010713:Phosphatidylcholines; D014665:Vasodilator Agents; D014304:Triolein; D002784:Cholesterol; D009529:Nicardipine; D009543:Nifedipine